The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via PEPFAR.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness associated with reduced risk for all-cause mortality.

Staff at the U.S. Centers for Disease Control and Prevention have been told to stop communication with the World Health Organization.

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

First-degree relatives of patients with celiac disease are at higher risk of also being afflicted; early screening among these patients is advised.

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

Patients with cryptogenic cirrhosis and definite celiac disease experienced significant clinical benefits when following a gluten-free diet.

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

Private equity acquisition of US hospitals was associated with a significant worsening of patient-reported care experiences.